William A. Albright
Finanzdirektor/CFO bei Xenogen Corp.
Profil
Mr. William A.
Albright, Jr. MBA, is Chief Financial Officer & Vice President at Xenogen Corp.
and Chief Financial Officer at Xlumena, Inc. He is on the Board of Directors at Falco Biotherapeutics BV.
Mr. Albright was previously employed as Chief Executive Officer by FlowMedica, Inc., President & Chief Executive Officer by Nexell Therapeutics, Inc., and Chief Financial Officer & Senior Vice President by LocalMed, Inc.
He received his undergraduate degree from Stanford University, a graduate degree from Stanford University, and an MBA from Harvard Business School.
Aktive Positionen von William A. Albright
Unternehmen | Position | Beginn |
---|---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Finanzdirektor/CFO | 07.01.2004 |
Falco Biotherapeutics BV
Falco Biotherapeutics BV Pharmaceuticals: MajorHealth Technology Falco Biotherapeutics BV operates as a biopharmaceutical company. It focuses on the development of (ElCams) engineered loop containing affinity molecules, a category of therapeutic, diagnostic, and prophylactic protein-based health care products to treat inflammation and infectious diseases. The company was founded in 2006 and is located in Amsterdam, The Netherlands | Direktor/Vorstandsmitglied | 31.07.2009 |
Ehemalige bekannte Positionen von William A. Albright
Unternehmen | Position | Ende |
---|---|---|
FlowMedica, Inc.
FlowMedica, Inc. Medical SpecialtiesHealth Technology FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA. | Präsident | 01.02.2004 |
Nexell Therapeutics, Inc.
Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Präsident | 01.12.2002 |
LocalMed, Inc.
LocalMed, Inc. Medical SpecialtiesHealth Technology LocalMed, Inc. manufactures medical devices for interventional cardiology. It provides analysis & data on pharma biotech device & diagnostic company strategy & trends.The company was founded by Aaron V. Kaplan and is headquartered in Palo Alto, CA. | Finanzdirektor/CFO | 01.09.1998 |
Xlumena, Inc.
Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Finanzdirektor/CFO | - |
Ausbildung von William A. Albright
Stanford University | Graduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
LocalMed, Inc.
LocalMed, Inc. Medical SpecialtiesHealth Technology LocalMed, Inc. manufactures medical devices for interventional cardiology. It provides analysis & data on pharma biotech device & diagnostic company strategy & trends.The company was founded by Aaron V. Kaplan and is headquartered in Palo Alto, CA. | Health Technology |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
FlowMedica, Inc.
FlowMedica, Inc. Medical SpecialtiesHealth Technology FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA. | Health Technology |
Nexell Therapeutics, Inc.
Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Health Technology |
Falco Biotherapeutics BV
Falco Biotherapeutics BV Pharmaceuticals: MajorHealth Technology Falco Biotherapeutics BV operates as a biopharmaceutical company. It focuses on the development of (ElCams) engineered loop containing affinity molecules, a category of therapeutic, diagnostic, and prophylactic protein-based health care products to treat inflammation and infectious diseases. The company was founded in 2006 and is located in Amsterdam, The Netherlands | Health Technology |
Xlumena, Inc.
Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Health Technology |